{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:00:56Z","timestamp":1759341656289},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.semarthrit.2010.12.002","type":"journal-article","created":{"date-parts":[[2011,2,4]],"date-time":"2011-02-04T09:15:33Z","timestamp":1296810933000},"page":"301-304","source":"Crossref","is-referenced-by-count":4,"title":["High-Dose Cyclophosphamide Without Stem Cell Rescue for the Treatment of Refractory Behcet's Disease"],"prefix":"10.1016","volume":"41","author":[{"given":"Charles F.","family":"Henderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.semarthrit.2010.12.002_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11926-010-0132-z","article-title":"Behcet's syndrome","volume":"12","author":"Yazici","year":"2010","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"10.1016\/j.semarthrit.2010.12.002_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.autrev.2009.10.005","article-title":"Etiopathogenesis of behcet's disease","volume":"9","author":"Mendoza-Pinto","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.12.002_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.revmed.2009.05.012","article-title":"Multiple arterial thrombosis in behcet's disease","volume":"31","author":"Kallel","year":"2010","journal-title":"Rev Med Interne"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.12.002_bib4","first-page":"829","article-title":"Venous involvement in Behcet's disease: A series of 28 cases","volume":"87","author":"Jamoussi","year":"2009","journal-title":"Tunis Med"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.12.002_bib5","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/ard.2008.087957","article-title":"Management of Behcet disease: A systematic literature review for the european league against rheumatism evidence-based recommendations for the management of Behcet disease","volume":"68","author":"Hatemi","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1-3","key":"10.1016\/j.semarthrit.2010.12.002_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12026-009-8149-y","article-title":"Brodsky RAHigh-dose cyclophosphamide for autoimmunity and alloimmunity","volume":"47","year":"2010","journal-title":"Immunol Res"},{"issue":"8697","key":"10.1016\/j.semarthrit.2010.12.002_bib7","first-page":"1078","article-title":"Criteria for diagnosis of Behcet's disease","volume":"335","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.12.002_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/rheumatology\/33.2.115","article-title":"Validation of the international study group criteria for Behcet's disease","volume":"33","author":"O'Neill","year":"1994","journal-title":"Br J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.12.002_bib9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/blood-2002-01-0087","article-title":"High-dose cyclophosphamide for refractory autoimmune hemolytic anemia","volume":"100","author":"Moyo","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.semarthrit.2010.12.002_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/ard.2007.077446","article-title":"High-dose cyclophosphamide without stem cell rescue in scleroderma","volume":"67","author":"Tehlirian","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.12.002_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/art.10752","article-title":"High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus","volume":"48","author":"Petri","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.12.002_bib12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood.V87.2.491.bloodjournal872491","article-title":"Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation","volume":"87","author":"Brodsky","year":"1996","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.semarthrit.2010.12.002_bib13","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1182\/blood.V75.10.1947.1947","article-title":"Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells","volume":"75","author":"Kastan","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2010.12.002_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1196\/annals.1405.033","article-title":"Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis","volume":"1132","author":"Drachman","year":"2008","journal-title":"Ann NY Acad Sci"},{"issue":"8","key":"10.1016\/j.semarthrit.2010.12.002_bib15","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archneurol.65.8.noc80042","article-title":"Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosis","volume":"65","author":"Krishnan","year":"2008","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.12.002_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mjd.2003.581","article-title":"Evaluating the role of immunoablative high-dose cyclophosphamide therapy in pemphigus vulgaris","volume":"49","author":"Nousari","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2010.12.002_bib17","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.7326\/0003-4819-129-12-199812150-00007","article-title":"Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease","volume":"129","author":"Brodsky","year":"1998","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.12.002_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.2005.035410","article-title":"Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involvement: Analysis after 5 years of follow up","volume":"65","author":"Maurer","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.12.002_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood-2003-10-3617","article-title":"Autologous hematopoietic stem cell transplantation for severe\/refractory intestinal Behcet disease","volume":"103","author":"Rossi","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.12.002_bib20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bmt.1705372","article-title":"Allogeneic bone marrow transplantation (BMT) for refractory Behcet's disease with severe CNS involvement","volume":"37","author":"Marmont","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.12.002_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/039463200702000110","article-title":"Prolonged remission of neuro-Behcet disease following autologous transplantation","volume":"20","author":"De Cata","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"10.1016\/j.semarthrit.2010.12.002_bib22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2009.013458","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases: An observational study on 12 years' experience from the European group for blood and marrow transplantation working party on autoimmune diseases","volume":"95","author":"Farge","year":"2010","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.semarthrit.2010.12.002_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/bmt.2008.424","article-title":"Allogeneic hematopoietic SCT for patients with autoimmune diseases","volume":"44","author":"Daikeler","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.semarthrit.2010.12.002_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/08916930802197206","article-title":"Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: Advantages and disadvantages","volume":"41","author":"Brodsky","year":"2008","journal-title":"Autoimmunity"},{"issue":"11","key":"10.1016\/j.semarthrit.2010.12.002_bib25","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1182\/blood-2009-06-225375","article-title":"High-dose cyclophosphamide for severe aplastic anemia: Long-term follow-up","volume":"115","author":"Brodsky","year":"2010","journal-title":"Blood"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017210002556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017210002556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T08:07:40Z","timestamp":1592294860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017210002556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0049017210002556"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2010.12.002","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}